Almitas Capital »

Acelyrin shares owned by Almitas Capital

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Almitas Capital from 13F filings

Historical chart of Almitas Capital investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Almitas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Almitas Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $121k 25k 4.93
2024-06-30 $1.7M 376k 4.41

More positions owned by Almitas Capital

Fidelity Wise Origin Bitcoin Fund SHS (FBTC)
BlackRock Health Sciences Term Trust Com Shs (BMEZ)
Nuveen PA Investnt Quality Municipal (NQP)
Miller/Howard High Dividend Fund Com Shs Ben In (HIE)
BlackRock Municipal 2030 Target Term Trust Com Shs Ben In (BTT)
Tortoise Midstream Energy M (NTG)
Mainstay Definedterm Mn Opp (MMD)
Bny Mellon Mun Income (DMF)
Pgim Short Dur Hig Yld Opp F (SDHY)
Design Therapeutics (DSGN)
Eaton Vance New York Municipal Bond Fund (ENX)
Amylyx Pharmaceuticals (AMLX)
Western Asset Invest. Grade Defined Opp (IGI)
BlackRock ESG Capital Allocation Term Trust Shs Ben Int (ECAT)
Tortoise Pipeline & Energy F (TTP)

View all positions for Almitas Capital

Top funds holding Acelyrin

T. Rowe Price Investment Management
AyurMaya Capital Management Company
Citadel Advisors
BlackRock
BlackRock
Vanguard Group
OrbiMed Advisors
venBio Partners
General Atlantic
Blue Owl Capital Holdings
Samsara BioCapital
Opaleye Management
Palo Alto Investors
Siren
Geode Capital Management

View all funds holding Acelyrin